Fig. 7: STAMBP expression predicts poor prognosis in TNBC. | Experimental & Molecular Medicine

Fig. 7: STAMBP expression predicts poor prognosis in TNBC.

From: The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability

Fig. 7

a Boxplot showing the relative expression of STAMBP in normal and breast cancer samples using the UALCAN web resource. b Box plot showing the relative expression of STAMBP in breast cancer based on nodal metastasis status using the UALCAN web resource. c Box plot showing the relative expression of STAMBP in breast cancer based on individual cancer stages using the UALCAN web resource. The mean ± SD. *p < 0.05. ns, not significant. d Association between STAMBP expression and breast cancer patient survival. Data analyses were performed using Kaplan‒Meier Plotter. e Representative images of STAMBP or RAI14 expression in human TNBC tissues (n = 10) and adjacent tissues (n = 10). Scale bars: 50 μm. The STAMBP or RAI14 staining intensity was quantified with Image-Pro Plus software (right graph). The mean ± SD (n = 10). *p < 0.05. f The correlation of STAMBP and RAI14 expression in the tumor (n = 10).

Back to article page